Rheum for Everyone, Episode 24 (video)| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

U.S. FDA Chief Gottlieb Resigns

Yasmeen Abutaleb  |  March 5, 2019

WASHINGTON (Reuters)—U.S. Food and Drug Administration (FDA) Chief Scott Gottlieb said he plans to step down in a month, calling into question how the agency will handle critical issues, such as e-cigarette use among teens and efforts to increase competition in prescription drugs. The U.S. Department of Health and Human Services (HHS), which oversees the…

Filed under:Professional Topics Tagged with:FDAFDA Commissioner Scott GottliebFood and Drug AdministrationU.S. Food and Drug Administration (FDA)

ACR Addresses the Rheumatology Workforce Shortage

Kelly Tyrrell  |  March 5, 2019

Analysis of the 2015 ACR Workforce Study, published in the April 2018 issue of Arthritis Care & Research, revealed the U.S. will face a shortage of 4,000 rheumatology providers by 2030.1 This shortage will be uneven, with rheumatology providers concentrated in urban and suburban areas, and rural areas underserved. The Central U.S., Southwest, Southeast and…

Filed under:Workforce Tagged with:fellowship training slotsloan forgivenesspediatric rheumatology slotsworkforce shortage

Practices Now Contributing to RheumPAC

Carina Stanton  |  March 5, 2019

Last year the ACR’s nonpartisan political action committee, RheumPAC, raised nearly $150,000 from individual contributors. Starting in 2019, the addition of the RheumPAC Advocacy Fund, where rheumatology practices and state societies can contribute corporate dollars, is expected to support RheumPAC fundraising efforts in an effort to surpass this dollar amount, giving rheumatology an even stronger…

Filed under:Legislation & AdvocacyPractice Support Tagged with:Kent “Kwas” Hustonrheumatology practicesRheumPACRheumPAC Advocacy FundZachary Wallace

3 Tips to Optimize Practice Performance

Carina Stanton  |  March 5, 2019

Rheumatologists can build resilience through recovery and reframing, transforming stress so that it enhances performance…

Filed under:Professional Topics Tagged with:burnoutlifestylephysician burnoutpractice performancequality of lifestress management

GI Disease in Early Systemic Sclerosis Associated with Worse Outcomes

Lara C. Pullen, PhD  |  March 5, 2019

In patients with systemic sclerosis (SSc), gastrointestinal disease may be associated with lower quality of life and increased risk of death. Research showed that SSc patients with severe GI disease had markers of muscle inflammation, skin fibrosis and vasculopathy…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:gastrointestinalgastrointestinal diseaseOutcomesSystemic sclerosis

History of Depression Is a Risk Factor for SLE in Women

Carina Stanton  |  February 28, 2019

Results from a 20-year, cohort study add to the evidence that depression increases the risk of developing an autoimmune disease, specifically SLE in women. Lead investigator Andrea Roberts, PhD, says, “There may be direct biological effects of depression that increase the risk of autoimmune disease.”…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:Depressionriskrisk factorSLEsystemic lupus erythematosus (SLE)Women

Nurse Practitioner & Physician Assistant Rheumatology Curriculum Outline Released

Mary Beth Nierengarten  |  February 25, 2019

A note from ARP President Hazel L. Breland, PhD, OTR/L, FAOTA: Some time has passed since the ACR first published its NP/PA Rheumatology Curriculum Outline. Originally developed to serve as a guide for rheumatologists to onboard a nurse practitioner (NP) or physician assistant (PA) into the rheumatology practice setting, the ACR has realized this valuable resource…

Filed under:Education & Training Tagged with:Association of Rheumatology Professionals (ARP)nurse practitionerphysician assistantRheumatology Curriculum Outline

The Effects of Early RA Treatment on CVD

Carina Stanton  |  February 19, 2019

New research exploring the effects of etanercept on cardiovascular disease in treatment-naive, early RA patients suggests a treatment advantage with etanercept, a TNF inhibitor and methotrexate over treatment with methotrexate and a conventional synthetic disease-modifying anti-rheumatic drug…

Filed under:ConditionsRheumatoid Arthritis Tagged with:biologic DMARDsconventional DMARDs (csDMARDS)Disease-modifying antirheumatic drugs (DMARDs)early RAetanerceptRheumatoid Arthritis (RA)

Dr. Yolanda López López, Rheumatologist & Writer

Carol Patton  |  February 18, 2019

Yolanda López López, MD, MA, a rheumatologist in Bayamón, Puerto Rico, says she’s been writing “forever.” But when she was in high school, several teachers, counselors and others persuaded her against selecting writing as a profession or even getting a college degree in literature because she wouldn’t be able to earn a comfortable living. At…

Filed under:AudioProfilesRheum After 5 Tagged with:Dr. Yolanda López López

Rheumatology Research Foundation Fuels Pipeline of Next-Gen Providers

From the College  |  February 18, 2019

One aspect of the Rheumatology Research Foundation’s work is recruiting more people into the field, and it starts by building interest in rheumatology among the best and brightest medical and graduate students. The Foundation is fueling the pipeline of rheumatology professionals by supporting students, residents and fellows in a number of ways, such as with…

Filed under:Education & TrainingFrom the CollegeResearch Rheum Tagged with:PreceptorshipRheumatology Research Foundation

  • « Previous Page
  • 1
  • …
  • 154
  • 155
  • 156
  • 157
  • 158
  • …
  • 333
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences